NCT06503393 2026-04-17
SENOVIE
Institut de Recherche pour le Developpement
Completed
Clinical Trials
14 trialsNCT03446547 2026-04-14
ASTEROID
Vastra Gotaland Region
Phase 2 Completed
NCT04375267 2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1 Completed
NCT02711202 2026-04-13
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Phase NA Completed
NCT02771405 2026-04-13
FRI-STC
National Hepatology & Tropical Medicine Research Institute
Phase 3 Completed
NCT04241367 2026-04-09
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
National Cancer Center, Korea
Completed
NCT04433156 2026-04-09
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
Phase 2 Completed
NCT04660097 2026-04-08
Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
Henan Cancer Hospital
Phase 2 Completed
NCT01022476 2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
NCT05394285 2026-04-06
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
Henan Cancer Hospital
Phase 2 Completed
NCT00116454 2026-04-03
Lipiocis
ANRS, Emerging Infectious Diseases
Phase 3 Completed
NCT06582498 2026-04-03
LIFE S-CAN
Fundació d'investigació Sanità ria de les Illes Balears
Phase NA Completed
NCT04122235 2026-03-30
LETSGO
Sorlandet Hospital HF
Phase NA Completed
NCT06807216 2026-03-24
YATAC
Defactum, Central Denmark Region
Phase NA Completed